Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.
Stephen Murphy, PhD
Advertisement
Articles by Stephen Murphy, PhD
Advertisement
Latest Updated Articles
- Projected US Savings From Biosimilars, 2021-2025
January 3rd 2022
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
3
Cranberry Supplement Tied to Greater OAB Score Reductions in Pilot Trial
4
Disease Extent Linked to Complications After Deep Endometriosis Surgery
5